Tuesday, July 26 3:30 – 4:30 p.m. Exhibit Hall Theater 1 Supported by EKF Diagnostics
Tests of glycated proteins, along with glucose, have been available for decades for the diagnosis and monitoring of diabetes mellitus. Hemoglobin A1C is considered to be the gold standard test and is used in the diagnosis, monitoring, and as the established risk predictor for complications. However, there are conditions that may adversely affect the HbA1c values and may result in inaccurate or misleading values. Alternative index tests such as fructosamine and glycated albumin (GA) may be appropriate in certain diabetic subpopulations. We will explore the strengths and limitations of different glycemic tests and introduce a new enzymatic method for GA.
After attending this session, participants will be able to:
William Shorter Global Product Manager - Diabetes
Shane O’Neil Global Director, Scientific Affairs
Takuji Kohzuma, PhD Senior Manager Asahi Kasei Pharma Corporation
Be the first to get all the latest news.